BTIG lowered the firm’s price target on Staar Surgical (STAA) to $39 from $49 and keeps a Buy rating on the shares as part of ...

BTIG analyst Ryan Zimmerman maintained a Buy rating on Staar Surgical (STAA – Research Report) today and set a price target of $39.00. The ...

It was revealed in a recent SEC filing that BROADWOOD PARTNERS LP, 10% Owner at Staar Surgical (NASDAQ:STAA) made a noteworthy insider purchase on December 19,. What Happened: In a recent Form 4 ...

In other STAAR Surgical news, major shareholder Broadwood Partners, L.P. purchased 23,000 shares of the firm’s stock in a transaction dated Wednesday, December 18th. The stock was acquired at an ...

STAAR Surgical (NASDAQ:STAA – Get Free Report) has earned an average rating of “Hold” from the nine research firms that are presently covering the company, MarketBeat Ratings reports.

LAKE FOREST, Calif., November 25, 2024--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for ...

BTIG lowered the firm’s price target on Staar Surgical (STAA) to $39 from $49 and keeps a Buy rating on the shares as part of a broader research note updating the firm’s models on Medical ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...